Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike G Martin

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
World Journal of Oncology|May 28, 2021
Personalized Medicine in Oncology in the Developing World: Barriers and Concepts to Improve <i>Status Quo</i>Adeoluwa Akeem Adeniji, Soniya Dulal, Mike G Martin
Clinical Lymphoma, Myeloma & Leukemia|January 17, 2015
Influence of insurance and marital status on outcomes of adolescents and young adults with acute lymphoblastic leukemiaAndrew E Fintel, Omer Jamy, Mike G Martin
Medical Oncology (Northwood, London, England)|April 15, 2017
9p24 abnormalities in hematologic malignancies with a focus on diffuse large B-cell lymphomaDilan A Patel, Andrew W Hahn, Mike G Martin
Pathology Oncology Research : POR|June 5, 2018
JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing in Solid Tumor PatientsMatthew K Stein, Lindsay K Morris, Mike G Martin
Leukemia Research|March 2, 2015
Early mortality in acute myeloid leukemiaAndrew Hahn, Smith Giri, George Yaghmour, et al.
Leukemia Research|March 13, 2009
Dicer and outcomes in patients with acute myeloid leukemia (AML)Mike G Martin, Jacqueline E Payton, Daniel C Link
Journal of Community Hospital Internal Medicine Perspectives|June 21, 2015
Sister Mary Joseph's nodule in a patient with metastatic small cell lung cancerSushil Ghimire, Smith Giri, Ranjan Pathak, et al.
Leukemia & Lymphoma|January 2, 2009
Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitorsMike G Martin, John F Dipersio, Geoffrey L Uy
Pathology Oncology Research : POR|November 22, 2018
Next-Generation Sequencing Identifies Novel RTK VUSs in Breast Cancer with an Emphasis on ROS1, ERBB4, ALK and NTRK3Matthew K Stein, Lindsay K Morris, Mike G Martin
Blood Advances|January 4, 2018
Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancyEric J Vick, Kruti Patel, Philippe Prouet, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
World Journal of Oncology|May 28, 2021
Personalized Medicine in Oncology in the Developing World: Barriers and Concepts to Improve <i>Status Quo</i>Adeoluwa Akeem Adeniji, Soniya Dulal, Mike G Martin
Clinical Lymphoma, Myeloma & Leukemia|January 17, 2015
Influence of insurance and marital status on outcomes of adolescents and young adults with acute lymphoblastic leukemiaAndrew E Fintel, Omer Jamy, Mike G Martin
Medical Oncology (Northwood, London, England)|April 15, 2017
9p24 abnormalities in hematologic malignancies with a focus on diffuse large B-cell lymphomaDilan A Patel, Andrew W Hahn, Mike G Martin
Pathology Oncology Research : POR|June 5, 2018
JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing in Solid Tumor PatientsMatthew K Stein, Lindsay K Morris, Mike G Martin
Leukemia Research|March 2, 2015
Early mortality in acute myeloid leukemiaAndrew Hahn, Smith Giri, George Yaghmour, et al.
Leukemia Research|March 13, 2009
Dicer and outcomes in patients with acute myeloid leukemia (AML)Mike G Martin, Jacqueline E Payton, Daniel C Link
Journal of Community Hospital Internal Medicine Perspectives|June 21, 2015
Sister Mary Joseph's nodule in a patient with metastatic small cell lung cancerSushil Ghimire, Smith Giri, Ranjan Pathak, et al.
Leukemia & Lymphoma|January 2, 2009
Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitorsMike G Martin, John F Dipersio, Geoffrey L Uy
Pathology Oncology Research : POR|November 22, 2018
Next-Generation Sequencing Identifies Novel RTK VUSs in Breast Cancer with an Emphasis on ROS1, ERBB4, ALK and NTRK3Matthew K Stein, Lindsay K Morris, Mike G Martin
Blood Advances|January 4, 2018
Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancyEric J Vick, Kruti Patel, Philippe Prouet, et al.
Pageof 7